Home
Clinical Trials
A Prospective Cohort Study on...

A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）

Last Updated: 2025-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center, prospective, non-interventional cohort study .

Its primary objectives are:

1. assess DILI patients' clinical characteristics, disease progression and influencing factors in clinical practice;
2. learn about suspected drug caused DILI,rechallenging, liver biochemical abnormalities mode, etc.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Prognostic Model for Drug-induced Liver Injury in China

NCT05060289

Drug-induced Liver Injury

RECRUITING

A Retrospective Study on Drug Induced Liver Injury in China

NCT02407964

Drug-Induced Liver Injury

COMPLETED

Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury

NCT04302506

Drug-induced Liver Injury

UNKNOWN

Drug-induced Liver Injury: Itching Study

NCT06446609

Drug Induced Liver Injury Pruritus

RECRUITING

Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)

NCT02061826

Drug-induced Liver Injury

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main purpose of this study is to understand patients with DILI clinical outcome and influencing factors in China's second and tertiary general hospitals (including Western medicine hospital, Chinese medicine hospital andIntegrated traditional Chinese and Western Medicine Hospital) and vulnerabilities of drug-induced liver injury specialist hospital (tuberculosis hospital, Pulmonary, etc.) in mainland.

The main purpose

1. assess the DILI patients' clinical outcomes and influencing factors in the real world;
2. learn about suspected drug caused DILI,rechallenging, liver biochemical abnormalities mode, etc.

Secondary objectives

1. assess the compliance of the DILI practice to the 2015 vision of the DILI guidelines in china.;
2. evaluate the histological features of DILI patients;
3. assessment DILI characteristics, prognosis and influencing factors in specific populations(such as the elderly, children with underlying liver disease background, etc.)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug-induced Liver Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.